CHI Report – Innovation in Hepatitis C Treatment – Page – 11
Todd E. Gillenwater, President and CEO, CHI-California Healthcare Institute
Dirk Calcoen, MD, Partner and Managing Director, The Boston Consulting Group
Laura Elias, PhD, Principal, The Boston Consulting Group
The authors would like to acknowledge Homie Razavi, PhD, the founder and managing director of the Center for Disease Analysis for extensive contributions to this report.
California Healthcare Institute (CHI)
CHI represents more than 275 leading biotechnology, medical device, diagnostics and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance biomedical research, investment, and innovation through effective advocacy of policies to improve public health and ensure the continued vitality of the life sciences sector. CHI’s website is www.chi.org. Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.
The Boston Consulting Group
The Boston Consulting Group (BCG) is a global management consulting firm and the world’s leading advisor on business strategy. We partner with clients from the private, public, and not-for-profit sectors in all regions to identify their highest-value opportunities, address their most critical challenges, and transform their enterprises. Our customized approach combines deep insight into the dynamics of companies and markets with close collaboration at all levels of the client organization. This ensures that our clients achieve sustainable competitive advantage, build more capable organizations, and secure lasting results. Founded in 1963, BCG is a private company with 81 offices in 45 countries.